跳至主要内容
临床试验/NCT02210351
NCT02210351Unknown不适用

Evaluation of Association Between Apical Dysfunction and Trans Apical Access for TAVR, in Patients With Severe Aortic Stenosis, Undergoing Trans Apical Trans Catheter Aortic Valve Replacement (TAP-TAVR).

Sheba Medical Center1 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2014年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
45
试验地点
1
主要终点
Change in left ventricle ejection fraction

研究概览

简要总结

The asses and evaluate whether trans apical access for TAVR is associated with apical dysfunction.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Severe aortic stenosis defined as aortic valve area of less than 1 cm2 or index area of 0.6 cm2/m2 by echocardiography.
  • •Symptomatic patients with aortic stenosis referred for medically indicated AVR
  • •Signed informed consent to participate in the study.

排除标准

  • •Inability to sign written informed consent.
  • •Abnormal Apical dysfunction at baseline
  • •LVEF < 20%
  • •Pregnancy or breast feeding.
  • •Need for emergency surgery for any reason.
  • •Any case in which the practicing physician asserts that enrollment in the protocol will

研究组 & 干预措施

MRI test

Experimental

干预措施: MRI test (Device)

结局指标

主要结局

Change in left ventricle ejection fraction

时间窗: two months after the surgery

次要结局

未报告次要终点

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Dr. Danny Spiegelstein

Dr. Danny Spiegelstein, Physician

Sheba Medical Center

研究点 (1)

Loading locations...

相似试验